FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Hillebrand James A

(Last) (First) (Middle)
PO BOX 32890

(Street)
LOUISVILLE KY 40232

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Stock Yards Bancorp, Inc. [ SYBT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
05/12/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock               478 (1) I Trust-Directors' Deferred Comp Plan
Common Stock               23,444 I KSOP-fbo James Hillebrand
Common Stock               11,634 I IRA-fbo Lynn Hillebrand
Common Stock 05/12/2022   M   28,054 A $ 15.26 114,998 D  
Common Stock 05/12/2022   F   17,090 D $ 54.71 97,908 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $ 35.9             02/20/2019 02/20/2028 Common Stock 7,423   7,423 D  
Stock Appreciation Right $ 15.26 05/12/2022   M     28,054 02/19/2014 02/19/2023 Common Stock 28,054 $ 0 0 D  
Stock Appreciation Right $ 19.37             02/18/2015 02/18/2024 Common Stock 16,425   16,425 D  
Stock Appreciation Right $ 22.96             03/17/2016 03/17/2025 Common Stock 12,319   12,319 D  
Stock Appreciation Right $ 40             03/21/2018 03/21/2027 Common Stock 7,571   7,571 D  
Stock Appreciation Right $ 25.76             03/15/2017 03/15/2026 Common Stock 14,428   14,428 D  
Stock Appreciation Right $ 39.32             10/01/2019 10/01/2028 Common Stock 25,000   25,000 D  
Stock Appreciation Right $ 36.65             02/19/2020 02/19/2029 Common Stock 12,254   12,254 D  
Stock Appreciation Right $ 37.3             02/25/2021 02/25/2030 Common Stock 14,482   14,482 D  
Stock Appreciation Right $ 50.71             02/25/2022 02/25/2031 Common Stock 8,615   8,615 D  
Stock Appreciation Right $ 54.91             02/14/2023 02/14/2032 Common Stock 10,142   10,142 D  
Explanation of Responses:
1. Includes shares acquired through automatic dividend reinvestment.
/s/ Donna Cleek, by power of attorney 05/16/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

sybt20220516_sec16.htm

 

LIMITED POWER OF ATTORNEY FOR REPORTING UNDER SECTION 16

REPORTING OBLIGATIONS

 

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Donna Cleek and Craig Bradley, or either of them acting singly and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

 

1.     execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer or director of Stock Yards Bancorp, Inc. (the “Company”), Forms 3, 4, and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder;

 

2.     do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendments thereto, and timely file any such form with the U.S. Securities and Exchange Commission (the “SEC”) and any securities exchange or similar authority, including without limitation the filing of a Form ID or any other documents necessary or appropriate to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC;

 

3.    seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned’s attorneys-in-fact appointed by this Limited Power of Attorney and approves and ratifies any such release of information; and

 

4.    take any other action in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such information and disclosure as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney and the rights and powers herein granted.

 

The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on the behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act.

 

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney as of this _28th_ day of __April_, 2022.

 

 

   

Signed and acknowledged:

 

 

 

/s/James A. Hillebrand__